US COPD Coalition

Keith Siegel


FDA Grants Emergency Use Authorization for Single-Dose Vaccine

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies, a subsidiary of Johnson & Johnson, for its single-shot COVID-19 vaccine. This marks the third vaccine to be awarded an emergency use authorization by the FDA. “This week marked a devastating milestone of 500,000 deaths from … Read more


NIH Announces Plans to Study “Long COVID”

Many patients who have been infected with SARS-CoV-2 experience multiple symptoms long after they have recovered from the initial stages of COVID-19 illness. The National Institutes of Health (NIH) has just announced a major new initiative to study this phenomenon with the goal of identifying its cause and how to treat and prevent it. “Often referred … Read more


USCC Joins Other Organizations in Advocacy Efforts

The US COPD Coalition (USCC) has recently signed on to two important letters.  One letter focuses on the need to address gaps in our system of delivery and supply of supplemental oxygen. The pandemic has put a strain on our supply of supplemental oxygen for home use due to the additional oxygen needs of COVID-19 … Read more


Solovy Award for Advancement in COPD: Call for Nominations

Respiratory Health Association, a member of the US COPD Coalition, invites you to submit nominations recognizing individuals who have made outstanding contributions to Chronic Obstructive Pulmonary Disease (COPD) research to improve the quality of life for those living with COPD. Purpose: This notice announces a nationwide call for award nominations for The Solovy Award for Advancement in … Read more


Clinical trial in hospitalized COVID-19 patients evaluates long-acting antibody therapy

The following article is re-printed from a news release by the National Institutes of Health NIH trial has begun enrolling participants. An international randomized, controlled Phase 3 clinical trial has begun evaluating the safety and efficacy of an investigational long-acting antibody combination for treating people hospitalized with COVID-19. The trial, part of a master protocol known as … Read more


NIH study shows hyaluronan is effective in treating chronic lung disease

The following article is re-printed from a news release by the National Institutes of Health Naturally produced by the body, hyaluronan represents a new class of biologic that significantly improves lung health in patients with severe COPD. Researchers at the National Institutes of Health and their collaborators found that inhaling unfragmented hyaluronan improves lung function … Read more


“COVID-19: Info You Can Trust” Webinar

What is the latest COVID-19 update? What should I know about the new strain of the virus? What do I need to know before getting a vaccine? Where do I go for answers and information that I can trust? We are nearly a full year into the COVID-19 pandemic, and we now have a deluge of information … Read more


Información de Salud en Español

The National Institutes of Health’s National Center for Integrative and Complementary Health offers information on complimentary health and other important healthcare topics in Spanish: Esta página brinda enlaces a recursos del NCCIH en español sobre medicina complementaria e integral. Además, incluye enlaces a otros recursos en español relacionados con la salud. Si usted utiliza medicina … Read more


Respiratory Compromise Institute Joins US COPD Coalition

The US COPD Coalition is pleased to welcome the Respiratory Compromise Institute (RCI) as its newest member organization. RCI is an alliance of professional medical societies and interested healthcare providers that have mobilized to define the state of Respiratory Compromise and educate the medical community so that the onset of respiratory compromise can be detected … Read more


New updates to federal guidelines revamp asthma management

The following is a news release from the National Institutes of Health. Updates to six key areas of asthma care focus on improving diagnosis, management and treatment. The National Institutes of Health today announced 19 recommendations in six key areas of asthma diagnosis, management and treatment. The new guidance, published in the Journal of Allergy and … Read more